• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

推荐负荷剂量后替考拉宁谷值在儿童中的评估及相关安全性分析

Evaluation of Teicoplanin Trough Values After the Recommended Loading Dose in Children With Associated Safety Analysis.

作者信息

Yamada Takaaki, Kubota Toshio, Yonezawa Mahoro, Nishio Hisanori, Kanno Shunsuke, Yano Takahisa, Kobayashi Daisuke, Egashira Nobuaki, Takada Hidetoshi, Hara Toshiro, Masuda Satohiro

机构信息

From the *Department of Pharmacy, Kyushu University Hospital, †Department of Clinical Pharmacy and Pharmaceutical care, Graduate School of Pharmaceutical Sciences, Kyushu University, and ‡Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

出版信息

Pediatr Infect Dis J. 2017 Apr;36(4):398-400. doi: 10.1097/INF.0000000000001456.

DOI:10.1097/INF.0000000000001456
PMID:27977550
Abstract

BACKGROUND

This study evaluated whether the recommended teicoplanin loading dose (3 loading doses of 10 mg/kg every 12 hours) achieves a 15-30 μg/mL trough levels in 26 children (2-16 years). In addition, we examined the incidences of renal impairment and hepatic dysfunction in children treated with teicoplanin.

METHODS

This retrospective study was conducted between October 2008 and March 2014.

RESULTS

The percentage of patients with a trough level <10 and <15 μg/mL were 15.4% (4/26) and 46.2% (12/26), respectively. There were significant correlations between age and concentration/cumulative loading dose (C/D) ratio (P = 0.045), serum creatinine and C/D ratio (P < 0.001) and estimated glomerular filtration rate and C/D ratio (P = 0.005). Serum creatinine was significantly lower when trough levels were <15 μg/mL compared with ≥15 μg/mL. The incidences of renal impairment and hepatic dysfunction were 2.3% and 5.8%, respectively, with no significant difference between <20 and ≥20 μg/mL trough-level groups.

CONCLUSIONS

The recommended loading dose may be insufficient to achieve 15-30 μg/mL in children with normal renal function. In addition, the target trough level ≥20 μg/mL for deep-seated infections seems to be safe in children.

摘要

背景

本研究评估了推荐的替考拉宁负荷剂量(每12小时3次10mg/kg的负荷剂量)是否能使26名2至16岁儿童的谷浓度达到15 - 30μg/mL。此外,我们还研究了接受替考拉宁治疗的儿童中肾功能损害和肝功能障碍的发生率。

方法

本回顾性研究于2008年10月至2014年3月进行。

结果

谷浓度<10μg/mL和<15μg/mL的患者百分比分别为15.4%(4/26)和46.2%(12/26)。年龄与浓度/累积负荷剂量(C/D)比之间存在显著相关性(P = 0.045),血清肌酐与C/D比之间存在显著相关性(P < 0.001),估计肾小球滤过率与C/D比之间存在显著相关性(P = 0.005)。谷浓度<15μg/mL时的血清肌酐显著低于≥15μg/mL时。肾功能损害和肝功能障碍的发生率分别为2.3%和5.8%,谷浓度<20μg/mL组和≥20μg/mL组之间无显著差异。

结论

对于肾功能正常的儿童,推荐的负荷剂量可能不足以使谷浓度达到15 - 30μg/mL。此外,对于深部感染,目标谷浓度≥20μg/mL对儿童似乎是安全的。

相似文献

1
Evaluation of Teicoplanin Trough Values After the Recommended Loading Dose in Children With Associated Safety Analysis.推荐负荷剂量后替考拉宁谷值在儿童中的评估及相关安全性分析
Pediatr Infect Dis J. 2017 Apr;36(4):398-400. doi: 10.1097/INF.0000000000001456.
2
Evaluation of teicoplanin concentrations and safety analysis in neonates.新生儿替考拉宁浓度评估及安全性分析。
Int J Antimicrob Agents. 2014 Nov;44(5):458-62. doi: 10.1016/j.ijantimicag.2014.07.005. Epub 2014 Aug 20.
3
Therapeutic Drug Level Monitoring of Teicoplanin in Korean Pediatric Patients with Normal versus Impaired Renal Function.替考拉宁在肾功能正常和受损的韩国儿科患者中的治疗药物浓度监测。
J Korean Med Sci. 2020 Nov 30;35(46):e376. doi: 10.3346/jkms.2020.35.e376.
4
Retrospective study of teicoplanin loading regimen that rapidly achieves target 15-30 μg/mL serum trough concentration.对能快速达到15 - 30μg/mL血清谷浓度目标的替考拉宁负荷剂量方案的回顾性研究。
J Infect Chemother. 2016 May;22(5):308-13. doi: 10.1016/j.jiac.2016.01.019. Epub 2016 Mar 5.
5
Development of initial loading procedure for teicoplanin in critically ill patients with severe infections.严重感染的危重症患者替考拉宁初始给药方案的制定。
Biol Pharm Bull. 2013;36(6):1024-6. doi: 10.1248/bpb.b12-00911.
6
Determination of teicoplanin trough concentration target and appropriate total dose during the first 3 days: a retrospective study in patients with MRSA infections.替考拉宁谷浓度目标值的确定和前 3 天的合适总剂量:MRSA 感染患者的回顾性研究。
J Infect Chemother. 2010 Jun;16(3):193-9. doi: 10.1007/s10156-010-0038-8. Epub 2010 Mar 2.
7
Enhanced loading regimen of teicoplanin is necessary to achieve therapeutic pharmacokinetics levels for the improvement of clinical outcomes in patients with renal dysfunction.对于肾功能不全患者,为达到治疗性药代动力学水平以改善临床结局,替考拉宁强化给药方案是必要的。
Eur J Clin Microbiol Infect Dis. 2016 Sep;35(9):1501-9. doi: 10.1007/s10096-016-2691-z. Epub 2016 Jun 9.
8
Evaluation of factors associated with the achievement of an optimal teicoplanin trough concentration
.与替考拉宁谷浓度达到最佳水平相关因素的评估
Int J Clin Pharmacol Ther. 2017 Aug;55(8):672-677. doi: 10.5414/CP203009.
9
Recommended initial loading dose of teicoplanin, established by therapeutic drug monitoring, and outcome in terms of optimal trough level.通过治疗药物监测确定的替考拉宁推荐初始负荷剂量以及最佳谷浓度方面的结果。
J Infect Chemother. 2006 Aug;12(4):185-9. doi: 10.1007/s10156-006-0446-y.
10
Clinical efficacy and safety in patients treated with teicoplanin with a target trough concentration of 20 μg/mL using a regimen of 12 mg/kg for five doses within the initial 3 days.治疗患者时采用替考拉宁目标谷浓度 20μg/mL,方案为初始 3 天内给予 12mg/kg,5 剂,观察临床疗效和安全性。
BMC Pharmacol Toxicol. 2020 Jul 8;21(1):50. doi: 10.1186/s40360-020-00424-3.

引用本文的文献

1
Incidence of Antimicrobial-Associated Acute Kidney Injury in Children: A Structured Review.儿童抗菌药物相关急性肾损伤的发生率:一项系统综述。
Paediatr Drugs. 2024 Jan;26(1):59-70. doi: 10.1007/s40272-023-00607-5. Epub 2023 Dec 13.
2
Optimal Use and Need for Therapeutic Drug Monitoring of Teicoplanin in Children: A Systematic Review.泰利霉素在儿童中的最佳使用和治疗药物监测需求:系统评价。
J Korean Med Sci. 2023 Feb 20;38(7):e62. doi: 10.3346/jkms.2023.38.e62.
3
Pharmacokinetics and pharmacodynamics of peptide antibiotics.肽类抗生素的药代动力学和药效学。
Adv Drug Deliv Rev. 2022 Apr;183:114171. doi: 10.1016/j.addr.2022.114171. Epub 2022 Feb 18.
4
Therapeutic Drug Level Monitoring of Teicoplanin in Korean Pediatric Patients with Normal versus Impaired Renal Function.替考拉宁在肾功能正常和受损的韩国儿科患者中的治疗药物浓度监测。
J Korean Med Sci. 2020 Nov 30;35(46):e376. doi: 10.3346/jkms.2020.35.e376.
5
Therapeutic Drug Monitoring and Nephrotoxicity of Teicoplanin Therapy in Chinese Children: A Retrospective Study.替考拉宁治疗中国儿童的治疗药物监测与肾毒性:一项回顾性研究
Infect Drug Resist. 2020 Nov 12;13:4105-4113. doi: 10.2147/IDR.S272982. eCollection 2020.
6
Population Pharmacokinetics and Dosage Optimization of Teicoplanin in Children With Different Renal Functions.替考拉宁在不同肾功能儿童中的群体药代动力学及剂量优化
Front Pharmacol. 2020 May 5;11:552. doi: 10.3389/fphar.2020.00552. eCollection 2020.
7
Tools for the Individualized Therapy of Teicoplanin for Neonates and Children.替考拉宁个体化治疗新生儿和儿童的工具。
Antimicrob Agents Chemother. 2017 Sep 22;61(10). doi: 10.1128/AAC.00707-17. Print 2017 Oct.